ArticlePloS one2026
Enhancing second harmonic generation-mediated photodynamic therapy via external electric field modulation.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photodynamic therapy (PDT) utilizes light-activated photosensitizers (PS) to produce reactive oxygen species (ROS) for targeted bacterial destruction; however, its efficacy is often limited by inadequate light penetration, necessitating novel enhancements, such as the integration of second harmonic generation (SHG) through harmonic nanoparticles (HNPs) that convert two photons into one of higher frequency, thereby advancing the approach of SHG-based PDT for improved bacterial eradication. Our novel technique explores the impact of an e (EEF) on SHG intensity to augment PDT efficacy against Staphylococcus aureus (S. aureus). We investigated a novel conjugate, Bismuth Ferrite (BFO) in conjunction with protoporphyrin IX (PPIX), and compared it to the Barium Titanate (BT)-PPIX conjugate, under EEF of 0 V, 10 V, and 20 V for a duration of 5 minutes. The experiments utilized a near-infrared (NIR) femtosecond pulsed laser at 798 nm for excitation. Our findings show that EEF significantly enhances SHG intensity, improving photodynamic activity. Notably, BFO-PPIX conjugates significantly decreased bacterial survival to 35.8 ± 3.0% under EEF exposure, in contrast to 48.1 ± 3.2% without EEF. Similarly, to further substantiate the impact of EEF on SHG-based PDT efficacy, BT-PPIX conjugates resulted in bacterial survival of 57.1 ± 1.0% with EEF exposure, in contrast to 78.4 ± 3.7% without EEF. Our findings confirm the first study of EEF-modulated SHG in PDT, demonstrating its capacity to augment SHG intensity in HNPs-PPIX conjugates and improve therapeutic efficacy. These results highlight the potential of SHG-enhanced PDT, particularly with optimized EEF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.